Diagnosis and treatment of ulcerative proctitis

被引:44
作者
Regueiro, MD
机构
[1] Univ Pittsburgh, Sch Med, Med Ctr 200, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15212 USA
[2] Univ Pittsburgh, Sch Med, Ctr Inflammatory Bowel Dis, Pittsburgh, PA 15212 USA
关键词
ulcerative proctitis; inflammatory bowel disease; topical; 5-amimosalicylates;
D O I
10.1097/01.mcg.0000139178.33502.a3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Proctitis refers to inflammation of the rectum, a diagnosis made by endoscopic evaluation. Symptoms of proctitis include rectal bleeding, urgency, tenesmus, diarrhea or constipation, and occasionally rectal pain. The causes of proctitis include infection, medication, ischemia, radiation, and ulcerative proctitis. Ulcerative proctitis is an important and increasingly common subcategory of ulcerative colitis (UC) in which inflammation is limited to the rectum. Historically, oral aminosalicylates have been the mainstay of acute and maintenance therapy. A growing body of data, however, indicates that topical aminosalicylates are effective first line agents in ulcerative proctitis and distal UC. Topical aminosalicylates act more effectively and rapidly to induce and maintain remission compared with their oral counterparts or topical steroids. Rarely ulcerative proctitis is refractory to topical therapy and in these instances systemic corticosteroids, antibiotics, immunomodulators, or surgery is required. This review highlights the pathogenesis, diagnosis, and treatment of ulcerative proctitis.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 38 条
[1]
AZADKHAN AK, 1977, LANCET, V2, P892
[2]
Inflammatory bowel disease - Medical therapy of specific clinical presentations [J].
Banerjee, S ;
Peppercorn, MA .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (01) :185-+
[3]
BETTER QUALITY OF THERAPY WITH 5-ASA COLONIC FOAM IN ACTIVE ULCERATIVE-COLITIS - A MULTICENTER COMPARATIVE TRIAL WITH 5-ASA ENEMA [J].
CAMPIERI, M ;
PAOLUZI, P ;
DALBASIO, G ;
BRUNETTI, G ;
PERA, A ;
BARBARA, L .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) :1843-1850
[4]
Campieri M, 1998, ALIMENT PHARM THER, V12, P361
[5]
5-AMINOSALICYLIC ACID AS ENEMAS OR SUPPOSITORIES IN DISTAL ULCERATIVE-COLITIS [J].
CAMPIERI, M ;
GIONCHETTI, P ;
BELLUZZI, A ;
BRIGNOLA, C ;
TABANELLI, GM ;
MIGLIOLI, M ;
BARBARA, L .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1988, 10 (04) :406-409
[6]
Cohen RD, 2000, AM J GASTROENTEROL, V95, P1263
[7]
Rectal pharmacokinetics of budesonide [J].
Dahlstrom, K ;
Edsbacker, S ;
Kallen, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 49 (04) :293-298
[8]
INTERMITTENT THERAPY WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS FOR MAINTAINING REMISSION IN ULCERATIVE PROCTOSIGMOIDITIS [J].
DALBASIO, G ;
TRALLORI, G ;
GHETTI, A ;
MILLA, M ;
NUCCI, A ;
PACINI, F ;
MORETTINI, A .
DISEASES OF THE COLON & RECTUM, 1990, 33 (05) :394-397
[9]
dAlbasio G, 1997, AM J GASTROENTEROL, V92, P1143
[10]
Dubinsky MC, 2001, AM J GASTROENTEROL, V96, P758